Effects of the timing of administration of oral small spherical activated charcoal (Kremezin) on the pharmacokinetics and pharmacodynamics of triazolam in humans.

Trial Profile

Effects of the timing of administration of oral small spherical activated charcoal (Kremezin) on the pharmacokinetics and pharmacodynamics of triazolam in humans.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Dec 2012

At a glance

  • Drugs Triazolam (Primary) ; Charcoal
  • Indications Insomnia
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 28 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top